Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol 1% Gel vs TCA 20% in Melasma
NCT07060157Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jul 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of resveratrol 1% gel in melasma (2 arms), sponsored by Assiut University. Primary endpoint: hemi-Melasma Area and Severity Index. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
resveratrol 1% gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07060157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07060157.